Corvus Pharmaceuticals (CRVS) had the highest return between April 1, 2023 and May 15, 2023 by a small-cap US stock, returning 195.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Corvus Pharmaceuticals (CRVS) | 4/1/2023 - 5/15/2023 | 195.45% |
P3 Health Partners (PIII) | 4/1/2023 - 5/15/2023 | 165.79% |
Sana Biotechnology (SANA) | 4/1/2023 - 5/15/2023 | 133.54% |
Pulse Biosciences (PLSE) | 4/1/2023 - 5/15/2023 | 133.53% |
National CineMedia (NCMI) | 4/1/2023 - 5/15/2023 | 108.85% |
Eyepoint Pharmaceuticals (EYPT) | 4/1/2023 - 5/15/2023 | 104.78% |
Olema Pharmaceuticals (OLMA) | 4/1/2023 - 5/15/2023 | 90.6% |
Akebia Ther (AKBA) | 4/1/2023 - 5/15/2023 | 89.83% |
Aquestive Therapeutics (AQST) | 4/1/2023 - 5/15/2023 | 86.96% |
Phathom Pharmaceuticals (PHAT) | 4/1/2023 - 5/15/2023 | 79.09% |
MiMedx (MDXG) | 4/1/2023 - 5/15/2023 | 78.24% |
Xeris Pharmaceuticals (XERS) | 4/1/2023 - 5/15/2023 | 73.17% |
Evolv Technologies (EVLV) | 4/1/2023 - 5/15/2023 | 70.23% |
X4 Pharmaceuticals (XFOR) | 4/1/2023 - 5/15/2023 | 68.89% |
Heritage Insurance Hldgs (HRTG) | 4/1/2023 - 5/15/2023 | 65.89% |
Fubotv (FUBO) | 4/1/2023 - 5/15/2023 | 61.67% |
Annexon (ANNX) | 4/1/2023 - 5/15/2023 | 58.22% |
Collective Mining (CNL) | 4/1/2023 - 5/15/2023 | 57.93% |
Arlo Technologies (ARLO) | 4/1/2023 - 5/15/2023 | 56.46% |
Prothena (PRTA) | 4/1/2023 - 5/15/2023 | 55.35% |
Sabre Corpo (SABR) | 4/1/2023 - 5/15/2023 | 54.3% |
Organogenesis (ORGO) | 4/1/2023 - 5/15/2023 | 51.43% |
Avalo Therapeutics (AVTX) | 4/1/2023 - 5/15/2023 | 48.65% |
American Coastal Insurance (ACIC) | 4/1/2023 - 5/15/2023 | 48.19% |
Oculis Holding AG Ordinary shares (OCS) | 4/1/2023 - 5/15/2023 | 47.66% |
Small-cap stocks are treated as having a market cap between $300M and $2B.